
Pulled from Benzinga Pro data, Progyny (NASDAQ:PGNY) showed a loss in earnings since Q3, totaling $15.08 million. Sales, on the other hand, increased by 4.31% to $127.55 million during Q4. In Q3, Progyny earned $16.80 million and total sales reached $122.28 million.